SM-Sino Technology Investment
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Germany, Hong Kong, Japan, Singapore, China, India, France, Indonesia, South Korea, Vietnam, Malaysia, Philippines, Israel, Thailand, Taiwan, Abu Dhabi, Cambodia, Brunei
Industries Focus
- Healthcare
- Healthcare Services
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Health and Wellness
- Medical Research
- Medical Equipment
- Health Insurance
- Healthcare IT
- Biopharmaceuticals
- Healthcare Consulting
- Medical Supplies
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2015
SM-Sino Technology Investment is a venture capital firm based in Seoul, South Korea, focusing on the healthcare sector, particularly biotechnology and pharmaceuticals. The firm identifies, incubates, and accelerates early-stage technologies and startups, providing comprehensive support to foster growth and innovation.
Established in 2015 by a team of venture capitalists, doctors, and entrepreneurs, SM-Sino Technology Investment operates an incubation center to support early-stage startups, offering resources and guidance to help them scale. The firm also acts as a business development manager for its portfolio companies, facilitating collaborations within the bio-ecosystem to enhance their market presence.
With a global perspective, SM-Sino Technology Investment seeks investment opportunities not only in South Korea but also in regions such as Vietnam, the United States, China, Hong Kong, Taiwan, Singapore, Indonesia, India, Japan, Thailand, Malaysia, the Philippines, Cambodia, Brunei, Abu Dhabi, Israel, the United Kingdom, France, and Germany. The firm's investment strategy encompasses seed, early-stage, late-stage, and pre-IPO investments, with funding sizes ranging from $1 million to $50 million, aiming to support the growth and success of its portfolio companies across various stages of development.
Requirements
- Innovative healthcare solutions
- Strong management teams
- Scalable business models
- Potential for significant market impact
- Alignment with firm's strategic focus areas
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Libentech
- IPP
- Oncocross
- April Bio
Claim this Investor
Are you an official representative of SM-Sino Technology Investment?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim